Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Dear Cancer Coach- I was diagnosed with multiple myeloma (MM) in march 2018 with 20% infiltrate pp 8.1 L/C 240 . LH Went up slowly to 480 consultant decided to start chemo of V/C/D. I have been taking CBD OIL, as an integrative therapy, since being diagnosed. I’m am now taking cannabis oil with THC.
First set of results looked very promising PP 4 L/C 170 second set PP3 LC240 which was disappointing haven’t had many side-effects apart form insomnia from the Dex .
Was taking omega 3, 2,000 mg daily and Turmeric/Curcumin 1200 mg daily, also as integrative therapies, then I started treatment. I stopped because was I was worried the supplementation might somehow stop the chemo working.
I just wondered what your thoughts were. I’m 52, fit and heathy, otherwise never had any side-effects its the mental side thats difficult for me.
Any advice you have would be very much appreciated. Thanks for sharing your time. Regards Peter
I am sorry to read of your MM diagnosis though it sounds as though you are doing well. I will break down your questions/comments below with questions and comments of my own.
“Combined curcumin and PS-341 treatment has been reported to enhance cytotoxicity and minimize adverse effects through ERK and p38MAPK mechanisms in human multiple myeloma cells…”
” Our study suggests that EPA and DHA induce selective cytotoxic effects in MM and increase sensitivity to bortezomib and calls for further exploration into a potential application of these n-3 polyunsaturated fatty acids in the therapy of MM….”
“Multiple myeloma (MM) is a plasma cell (PC) malignancy characterised by the accumulation of a monoclonal PC population in the bone marrow (BM).
Cannabidiol (CBD) is a non-psychoactive cannabinoid with antitumoural activities, and the transient receptor potential vanilloid type-2 (TRPV2) channel has been reported as a potential CBD receptor.
TRPV2 activation by CBD decreases proliferation and increases susceptibility to drug-induced cell death in human cancer cells. However, no functional role has been ascribed to CBD and TRPV2 in MM.
In this study, we identified the presence of heterogeneous CD138+TRPV2+ and CD138+TRPV2- PC populations in MM patients, whereas only the CD138+ TRPV2- population was present in RPMI8226 and U266 MM cell lines.
Because bortezomib (BORT) is commonly used in MM treatment, we investigated the effects of CBD and BORT in CD138+TRPV2- MM cells and in MM cell lines transfected with TRPV2 (CD138+TRPV2+).
These results showed that CBD by itself or in synergy with BORT strongly inhibited growth, arrested cell cycle progression and induced MM cells death by regulating the ERK, AKT and NF-κB pathways with major effects in TRPV2+ cells.
These data provide a rationale for using CBD to increase the activity of proteasome inhibitors in MM.”